Glaxo's Witty Lists 'Fundamentals' For Consumer Business Prowess
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
Andrew Witty tells analysts Glaxo is strong in areas critical to success in the consumer health products space: margin, scale and potential OTC switches. The Flonase Allergy Relief OTC switch shows "nobody is switching products better than GSK," he says.